328 related articles for article (PubMed ID: 16960105)
1. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.
Kolodgie FD; Burke AP; Skorija KS; Ladich E; Kutys R; Makuria AT; Virmani R
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2523-9. PubMed ID: 16960105
[TBL] [Abstract][Full Text] [Related]
2. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
3. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
4. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study.
Otsuka F; Kramer MC; Woudstra P; Yahagi K; Ladich E; Finn AV; de Winter RJ; Kolodgie FD; Wight TN; Davis HR; Joner M; Virmani R
Atherosclerosis; 2015 Aug; 241(2):772-82. PubMed ID: 26058741
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 as a target of therapy.
Macphee CH; Nelson JJ; Zalewski A
Curr Opin Lipidol; 2005 Aug; 16(4):442-6. PubMed ID: 15990594
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
[TBL] [Abstract][Full Text] [Related]
7. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
8. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.
Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions].
Zhong Y; Ye F; You W; Wu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):566-571. PubMed ID: 28738484
[No Abstract] [Full Text] [Related]
10. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.
Iribarren C; Gross MD; Darbinian JA; Jacobs DR; Sidney S; Loria CM
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):216-21. PubMed ID: 15499045
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A(2) and atherosclerosis.
Wilensky RL; Macphee CH
Curr Opin Lipidol; 2009 Oct; 20(5):415-20. PubMed ID: 19667981
[TBL] [Abstract][Full Text] [Related]
12. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
13. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
16. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
[No Abstract] [Full Text] [Related]
17. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.
Fenning RS; Burgert ME; Hamamdzic D; Peyster EG; Mohler ER; Kangovi S; Jucker BM; Lenhard SC; Macphee CH; Wilensky RL
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25672369
[TBL] [Abstract][Full Text] [Related]
19. Intraplaque hemorrhage and progression of coronary atheroma.
Kolodgie FD; Gold HK; Burke AP; Fowler DR; Kruth HS; Weber DK; Farb A; Guerrero LJ; Hayase M; Kutys R; Narula J; Finn AV; Virmani R
N Engl J Med; 2003 Dec; 349(24):2316-25. PubMed ID: 14668457
[TBL] [Abstract][Full Text] [Related]
20. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
Brilakis ES; McConnell JP; Lennon RJ; Elesber AA; Meyer JG; Berger PB
Eur Heart J; 2005 Jan; 26(2):137-44. PubMed ID: 15618069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
